Skip to Primary Navigation

Skip to main content

Former pharma CEO agrees $30k settlement with SEC over fraud allegations

Anthony J Cataldo, who was accused of diverting millions in company funds, agreed to settle fraud allegations for a fraction of the amount regulators say he stole.

Premium article

Kevin Kinsella

A photo of the front of the headquarters of the U.S. Securities and Exchange Commission.
Photo by Anna Moneymaker/Getty Images
Click to share on Facebook (Opens in new window/tab) Click to share on X (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

A former pharmaceutical executive has agreed to settle federal charges accusing him of siphoning more $3.2m from the company he once led, according to a complaint filed by the SEC.

Regulators allege that between November 2020 and October 2021, Anthony J Cataldo repeatedly transferred corporate funds into his personal bank

, , , , , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial
Sign in

What’s included:

  • Every new article, plus our 6,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience